These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 1996570)
1. Hemodynamic effects of partial correction of chronic anemia by recombinant human erythropoietin in patients on dialysis. Mayer G; Cada EM; Watzinger U; Barnas U; Graf H Am J Kidney Dis; 1991 Mar; 17(3):286-9. PubMed ID: 1996570 [TBL] [Abstract][Full Text] [Related]
2. Effect of recombinant human erythropoietin therapy on ambulatory blood pressure in normotensive and in untreated borderline hypertensive hemodialysis patients. Lebel M; Kingma I; Grose JH; Langlois S Am J Hypertens; 1995 Jun; 8(6):545-51. PubMed ID: 7662237 [TBL] [Abstract][Full Text] [Related]
3. [Treatment of anemia in hemodialysis patients using recombinant human erythropoietin: advantages and disadvantages]. Zehnder C; Blumberg A Schweiz Med Wochenschr; 1989 Mar; 119(9):269-75. PubMed ID: 2711161 [TBL] [Abstract][Full Text] [Related]
4. Hemodynamics of patients with renal failure treated with recombinant human erythropoietin. Verbeelen D; Bossuyt A; Smitz J; Herman A; Dratwa M; Jonckheer MH Clin Nephrol; 1989 Jan; 31(1):6-11. PubMed ID: 2914412 [TBL] [Abstract][Full Text] [Related]
5. Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: a prospective study. Pascual J; Teruel JL; Moya JL; Liaño F; Jiménez-Mena M; Ortuño J Clin Nephrol; 1991 Jun; 35(6):280-7. PubMed ID: 1831414 [TBL] [Abstract][Full Text] [Related]
6. Iron deficiency in patients with dialysis-associated anemia during erythropoietin replacement therapy: strategies for assessment and management. Van Wyck DB Semin Nephrol; 1989 Mar; 9(1 Suppl 2):21-4. PubMed ID: 2669082 [TBL] [Abstract][Full Text] [Related]
7. [Multicenter study of darbepoetin alfa in the treatment of anemia secondary to chronic renal insufficiency on dialysis]. Martínez Castelao A; Reyes A; Valdés F; Otero A; López de Novales E; Pallardó L; Tabernero JM; Hernández Jaras J; Lladós F Nefrologia; 2003; 23(2):114-24. PubMed ID: 12778875 [TBL] [Abstract][Full Text] [Related]
8. Influence of the 6-month anemia therapy with erythropoietin on renal function and some hemodynamic parameters in predialysis patients. Tomczak-Watras W; Strózecki P; Zuchora Z; Szefer J; Manitius J Pol Arch Med Wewn; 2009; 119(1-2):45-51. PubMed ID: 19341178 [TBL] [Abstract][Full Text] [Related]
9. [An echocardiographic study of the left ventricular functional indices in pediatric patients on hemodialysis and in treatment with recombinant human erythropoietin (r-HuEPO)]. Seracini D; Pollini I; Lavoratti GC; Pela I; Materassi M; Danti D; De Simone L; Favilli S; Manetti A Pediatr Med Chir; 1994; 16(4):389-92. PubMed ID: 7816703 [TBL] [Abstract][Full Text] [Related]
10. Effect of recombinant human erythropoietin treatment on hemodynamic parameters in continuous ambulatory peritoneal dialysis and hemodialysis patients. Fernández A; Vega N; Jiménez F; Macía M; Laraudiogoitía E; Hortal L; Perdomo M; Plaza C; Rodríguez JC; Palop L Am J Nephrol; 1992; 12(4):207-11. PubMed ID: 1481867 [TBL] [Abstract][Full Text] [Related]
11. [Treatment of anemia in chronically dialyzed patients]. Moynot A Nephrologie; 1998; 19(3):125-7. PubMed ID: 9633055 [No Abstract] [Full Text] [Related]
12. [Successful treatment of anemia in hemolysis patients using recombinant human erythropoietin. Maintenance dosage and serum concentration]. Stutz B; Rhyner K; Vögtli J; Binswanger U Schweiz Med Wochenschr; 1987 Sep; 117(38):1397-402. PubMed ID: 3672079 [TBL] [Abstract][Full Text] [Related]
13. Hemodynamic and volume changes by recombinant human erythropoietin (rHuEPO) in the treatment of anemic hemodialysis patients. Hori K; Onoyama K; Iseki K; Fujimi S; Fujishima M Clin Nephrol; 1990 Jun; 33(6):293-8. PubMed ID: 2376091 [TBL] [Abstract][Full Text] [Related]
14. Renal function during erythropoietin therapy for anemia in predialysis chronic renal failure patients. Abraham PA; Opsahl JA; Rachael KM; Asinger R; Halstenson CE Am J Nephrol; 1990; 10(2):128-36. PubMed ID: 2349956 [TBL] [Abstract][Full Text] [Related]
15. [The treatment of anemia of hemodialysis patients using recombinant human erythropoietin: comparison between intravenous and subcutaneous administration]. Zehnder C; Blumberg A Schweiz Med Wochenschr; 1990 Feb; 120(7):217-20. PubMed ID: 2309110 [TBL] [Abstract][Full Text] [Related]
16. [Clinical studies of recombinant human erythropoietin in patients on long-term dialysis]. Ji SM; Li LS; Ji DX Zhonghua Nei Ke Za Zhi; 1993 Feb; 32(2):100-2. PubMed ID: 8404323 [TBL] [Abstract][Full Text] [Related]
17. Vascular changes in hemodialysis patients in response to recombinant human erythropoietin. London GM; Zins B; Pannier B; Naret C; Berthelot JM; Jacquot C; Safar M; Drueke TB Kidney Int; 1989 Nov; 36(5):878-82. PubMed ID: 2615194 [TBL] [Abstract][Full Text] [Related]
18. The use of recombinant human erythropoietin in the correction of anemia in predialysis patients and its effect on renal function: a double-blind, placebo-controlled trial. Kleinman KS; Schweitzer SU; Perdue ST; Bleifer KH; Abels RI Am J Kidney Dis; 1989 Dec; 14(6):486-95. PubMed ID: 2688405 [TBL] [Abstract][Full Text] [Related]
19. The effects of maintenance recombinant human erythropoietin therapy on ambulatory blood pressure recordings: conventional, Doppler, and tissue Doppler echocardiographic parameters. Kirkpantur A; Kahraman S; Yilmaz R; Arici M; Altun B; Erdem Y; Yasavul U; Turgan C Artif Organs; 2005 Dec; 29(12):965-72. PubMed ID: 16305652 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerance of treatment with recombinant-human erythropoietin in chronic renal failure (pre-dialysis) patients. Frenken LA; Verberckmoes R; Michielsen P; Koene RA Nephrol Dial Transplant; 1989; 4(9):782-6. PubMed ID: 2516609 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]